01-10-2019 | Epstein-Barr Virus | Letter to the Editor
Low-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab
Published in: Annals of Hematology | Issue 10/2019
Login to get access